Literature DB >> 27741212

Breast Cancer Screening, Mammography, and Other Modalities.

James V Fiorica1.   

Abstract

This article is an overview of the modalities available for breast cancer screening. The modalities discussed include digital mammography, digital breast tomosynthesis, breast ultrasonography, magnetic resonance imaging, and clinical breast examination. There is a review of pertinent randomized controlled trials, studies and meta-analyses which contributed to the evolution of screening guidelines. Ultimately, 5 major medical organizations formulated the current screening guidelines in the United States. The lack of consensus in these guidelines represents an ongoing controversy about the optimal timing and method for breast cancer screening in women. For mammography screening, the Breast Imaging Reporting and Data System lexicon is explained which corresponds with recommended clinical management. The presentation and discussion of the data in this article are designed to help the clinician individualize breast cancer screening for each patient.

Entities:  

Mesh:

Year:  2016        PMID: 27741212     DOI: 10.1097/GRF.0000000000000246

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  20 in total

1.  Patients with oral preneoplastic lesions and integration of dental pathology referrals.

Authors:  Rachel Thompson; Jayson Haws; Nelson L Rhodus; Frank G Ondrey
Journal:  Am J Otolaryngol       Date:  2021-10-20       Impact factor: 1.808

2.  Diagnostic accuracy and prognostic value of three-dimensional electrical impedance tomography imaging in patients with breast cancer.

Authors:  Feng Xu; Mengxin Li; Jie Li; Hongchuan Jiang
Journal:  Gland Surg       Date:  2021-09

Review 3.  Advances in breast cancer screening modalities and status of global screening programs.

Authors:  Chenyu Luo; Le Wang; Yuhan Zhang; Ming Lu; Bin Lu; Jie Cai; Hongda Chen; Min Dai
Journal:  Chronic Dis Transl Med       Date:  2022-05-25

4.  Application of Machine Learning Algorithms in Breast Cancer Diagnosis and Classification.

Authors:  Clement G Yedjou; Solange S Tchounwou; Richard A Aló; Rashid Elhag; BereKet Mochona; Lekan Latinwo
Journal:  Int J Sci Acad Res       Date:  2021-10-30

5.  Analysing the Insights and Assessing the Impact of a Digital Mammography and Tomosynthesis Based 2-year Long Prospective Breast Screening Programme Organised in Western India.

Authors:  Pranav Ajmera; Pratiksha Yadav; Udayan Dosi; Shreeya Goyal
Journal:  Asian Pac J Cancer Prev       Date:  2022-01-01

6.  APC gene promoter aberrant methylation in serum as a biomarker for breast cancer diagnosis: A meta-analysis.

Authors:  Xiaojun Qian; Liwei Ruan
Journal:  Thorac Cancer       Date:  2018-01-03       Impact factor: 3.500

7.  Associations Between PET Parameters and Expression of Ki-67 in Breast Cancer.

Authors:  Alexey Surov; Hans Jonas Meyer; Andreas Wienke
Journal:  Transl Oncol       Date:  2018-12-03       Impact factor: 4.243

8.  Impact of full field digital mammography diagnosis for female patients with breast cancer.

Authors:  Tuan Wang; Jian-Jun Shuai; Xing Li; Zhi Wen
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

9.  A multicenter study of a contrast-enhanced ultrasound diagnostic classification of breast lesions.

Authors:  Lina Tang; Yijie Chen; Zhongshi Du; Zhaoming Zhong; Qin Chen; Lichun Yang; Ruoxia Shen; Yan Cheng; Zizhen Zhang; Ehui Han; Zhihong Lv; Lijun Yuan; Yong Yang; Yinrong Cheng; Lei Yang; Shengli Wang; Baoyan Bai; Jun Luo
Journal:  Cancer Manag Res       Date:  2019-03-15       Impact factor: 3.989

10.  The Usefulness of Spectral Mammography in Surgical Planning of Breast Cancer Treatment-Analysis of 999 Patients with Primary Operable Breast Cancer.

Authors:  Andrzej Lorek; Katarzyna Steinhof-Radwańska; Anna Barczyk-Gutkowska; Wojciech Zarębski; Piotr Paleń; Karol Szyluk; Joanna Lorek; Anna Grażyńska; Paweł Niemiec; Iwona Gisterek
Journal:  Curr Oncol       Date:  2021-07-12       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.